Since CCL25 was able to induce collagen type I and PG production in AF cells it might be an interesting candidate for our overall aim to establish a regenerative approach for AF closure, based on implantation of biomaterials supplemented with growth/differentiation factors and/or cell recruiting factors. The gene discussed is CCL25; the disease is atrial fibrillation.